Macro
Skymap Pharmaceuticals Wins IMPCL Disinvestment with Rs 121 Crore Bid
Government approves Skymap Pharmaceuticals as strategic buyer for 100% disinvestment of IMPCL at Rs 121.01 crore.
Transaction completed through two-stage competitive bidding process with seven initial
